Browse by category

Bariatric surgery associated with reduced risk of recurrent stroke hospitalisation among older stroke survivors with obesity

Hospitalisations for recurrent stroke decreased over time in patients who had undergone bariatric surgery compared to those who had not,...

Ten years in endobariatrics – the past, present and future

Bariatric News talked to Letizia Ceccarelli, Head of International Marketing – Endobariatrics at Boston Scientific about the changes she...

Journal watch 28/08/2024

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Olympus launches new Powerseal Sealer/Divider 5mm devices extending advanced bipolar surgical energy portfolio

Olympus has launched two new jaw designs in the Powerseal Sealer/Divider range of advanced bipolar surgical energy products: the...

Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity

Eli Lilly and Company has announced Zepbound (tirzepatide) 2.5mg and 5mg single-dose vials are available for self-pay for patients with...

One in seven Medicare beneficiaries with high BMI and established CVD may qualify for OMMs adding $34 billion to costs

Current federal regulation restricts Medicare from covering obesity management medications (OMMs) prescribed solely for weight loss....

Semaglutide’s cardiac benefits extend to people with heart failure

The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events (MACE) among people...

Sharp rise in the numbers young Chinese people diagnosed with obesity-related cancers

Obesity-related cancer rates in China were rising at an alarming 3.6% every year between 2007 and 2021, while non-obesity-related cancers...

Titan SGS stapler results in shorter length of hospital stay, fewer readmissions, reduced post-operative nausea/vomiting events and operative times

Patients undergoing laparoscopic sleeve gastrectomy (LSG) using the latest Titan SGS single-fire stapler (developed by Standard...

Tirzepatide reduced the risk of developing T2Dm by 94% in adults with pre-diabetes and obesity or overweight

Eli Lilly and Company has announced positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating...

Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays

8 hours ago

Journal Watch 18/12/2024

12 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

12 hours ago

Weekly Digest